Value2021202220232024TTMCash from investing activities———-21.97 M71.47 MCash from financing activities———142.09 M-83 KFree cash flow———-67.85 M-72.58 M
Silence Therapeutics Plc - American Depository Share
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.